Related Experiment Video
Updated: Sep 26, 2026
06:55
An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
Depression and ischemic heart disease: overview of the evidence and treatment implications
Wei Jiang1, James A Blumenthal
1Department of Psychiatry and Behavioral Science, Duke University Medical Center, Box 3366, Durham, NC 27710, USA. jiang001@mc.duke.edu
Current Psychiatry Reports
|April 11, 2003
Insights
This review examines depression as a risk factor for ischemic heart disease (IHD). It also assesses depression treatments for patients already diagnosed with IHD.
Area of Science:
- Cardiology
- Psychiatry
- Public Health
Background:
- Depression is increasingly recognized as a significant risk factor for cardiovascular diseases.
- Ischemic heart disease (IHD) is a leading cause of mortality worldwide.
- The interplay between mental health and cardiovascular health requires further investigation.
Purpose of the Study:
- To synthesize current evidence linking depression to the development of ischemic heart disease.
- To evaluate the effectiveness and safety of various depression treatment modalities in patients with established IHD.
Main Methods:
- Systematic literature review of observational studies and clinical trials.
- Analysis of epidemiological data and meta-analyses on depression and IHD risk.
- Assessment of randomized controlled trials (RCTs) on antidepressant efficacy and safety in IHD populations.
Main Results:
- Consistent evidence supports depression as an independent risk factor for IHD incidence and progression.
- Certain antidepressant therapies show potential benefits in managing depression symptoms in IHD patients.
- Safety profiles of depression treatments in this vulnerable population require careful consideration.
Conclusions:
- Addressing depression is crucial for comprehensive cardiovascular risk management.
- Further research is needed to optimize depression treatment strategies for IHD patients.
- Integrated care models may improve outcomes for individuals with comorbid depression and IHD.
Abstract:
In this article, the authors review the evidence that depression is a risk factor for ischemic heart disease and examine the efficacy and safety of depression treatments in patients with ischemic heart disease.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...